Winsome Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-12-2024
- Paid Up Capital ₹ 0.50 M
as on 15-12-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 6.02%
(FY 2022)
- Profit 68.78%
(FY 2022)
- Ebitda 97.82%
(FY 2022)
- Net Worth -5.17%
(FY 2022)
- Total Assets -3.14%
(FY 2022)
About Winsome Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Tyagi, Inder Gandhi, Sanjay Taneja, and One other member serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PLC070873
- Company No.
070873
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jul 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Winsome Laboratories Limited offer?
Winsome Laboratories Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Vitamin D Tablets, HIV Drugs, Personal Care, Oral Care.
Who are the key members and board of directors at Winsome Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Tyagi  | Director | 17-Jul-1995 | Current |
| Inder Gandhi | Director | 17-Jul-1995 | Current |
| Sanjay Taneja | Director | 17-Jul-1995 | Current |
| Renuka Tyagi | Director | 17-Jul-1995 | Current |
Financial Performance of Winsome Laboratories.
Winsome Laboratories Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.02% increase. The company also saw a substantial improvement in profitability, with a 68.78% increase in profit. The company's net worth dipped by a decrease of 5.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Winsome Laboratories?
In 2022, Winsome Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Winsome Bioceuticals Private LimitedActive 5 years 4 monthsInder Gandhi and Sanjay Taneja are mutual person
- Mentis Pharma LimitedActive 22 years 2 months
Ashok Tyagi, Inder Gandhi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Winsome Laboratories?
Winsome Laboratories has a workforce of 42 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winsome Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winsome Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
